Emami Limited is strengthening its foothold in the ayurvedic and wellness space with a strategic majority acquisition of Axiom Ayurveda Private Limited. The Kolkata-based FMCG giant has signed a share purchase agreement to acquire a total 73.5% stake in the company, turning it into a subsidiary.
Emami, which already held a 26.5% stake, has completed the first tranche of the deal by acquiring an additional 36.7% stake-equivalent to over 84 lakh equity shares-on April 1, 2026. The remaining 36.7% will be acquired in a second tranche, expected to close by June 2026, finalising the full majority takeover.
This move aligns with Emami’s larger strategy to scale its presence in high-growth, digital-first and wellness-driven categories. The company’s new-age portfolio, including brands like The Man Company and Brillare, has already shown strong momentum, posting a 31% year-on-year growth in Q3 FY26.
Driving this growth are factors such as premium product innovation, focused digital marketing, and expansion across quick commerce and direct-to-consumer (D2C) platforms. Emami’s leadership has highlighted digital channels as a key growth engine, with consistent quarter-on-quarter acceleration.
Financially, the company continues to remain robust. In Q3 FY26, Emami reported an 11% increase in net sales to ₹1,152 crore, with domestic business also growing at 11%, supported by a 9% volume rise. Profit after tax rose 15% to ₹319 crore.
The Axiom Ayurveda acquisition signals more than just expansion-it reflects Emami’s intent to build a future-ready portfolio rooted in wellness, digital distribution, and evolving consumer preferences.
